Literature DB >> 7690491

Prevalence and clinical significance of dilated Virchow-Robin spaces in childhood.

N K Rollins1, C Deline, M C Morriss.   

Abstract

PURPOSE: To determine the prevalence and clinical significance of dilated Virchow-Robin spaces in pediatric patients.
MATERIALS AND METHODS: Cranial magnetic resonance (MR) studies of 1,250 children who underwent imaging during 12 consecutive months were prospectively evaluated.
RESULTS: Thirty-seven patients had prominent Virchow-Robin spaces. The most common indications for imaging in these patients were headache (n = 10), developmental delay (n = 8), and psychiatric problems (n = 7). Medical records revealed that 12 of the 37 patients had severe headaches, 17 had moderate or severe delay in development, and 18 had serious behavioral or psychiatric problems. An association was found between presence or absence of dilated Virchow-Robin spaces and presence or absence of developmental delay (odds ratio = 4.9; 95% confidence interval [CI] = 2.1, 11.1; P < .001), psychiatric problems (odds ratio = 12.6; 95% CI = 5.0, 31.8; P < .001), and headaches (odds ratio = 37; 95% CI = 14.7, 93.2; P < .001).
CONCLUSION: There appears to be a correlation between functional neuropsychiatric disorders in children and the presence of Virchow-Robin spaces in the cerebral hemispheres at MR imaging.

Entities:  

Mesh:

Year:  1993        PMID: 7690491     DOI: 10.1148/radiology.189.1.7690491

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

1.  Multi-cystic white matter enlarged Virchow Robin spaces in a 5-year-old boy.

Authors:  Erhan Bayram; Gulcin Akinci; Yasemin Topcu; Handan Cakmakci; Ozlem Giray; Derya Ercal; Semra Hiz
Journal:  Childs Nerv Syst       Date:  2011-12-29       Impact factor: 1.475

Review 2.  [Clinical relevance of normal and enlarged Virchow-Robin spaces].

Authors:  B Gess; T U Niederstadt; E B Ringelstein; W R Schäbitz
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

3.  Dilated perivascular spaces: hallmarks of mild traumatic brain injury.

Authors:  Matilde Inglese; Elan Bomsztyk; Oded Gonen; Lois J Mannon; Robert I Grossman; Henry Rusinek
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

Review 4.  Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature.

Authors:  Samuel Groeschel; Wui Khean Chong; Robert Surtees; Folker Hanefeld
Journal:  Neuroradiology       Date:  2006-08-05       Impact factor: 2.804

5.  Brain Perivascular Spaces as Biomarkers of Vascular Risk: Results from the Northern Manhattan Study.

Authors:  J Gutierrez; M S V Elkind; C Dong; M Di Tullio; T Rundek; R L Sacco; C B Wright
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-24       Impact factor: 3.825

Review 6.  Hypomelanosis of Ito and brain abnormalities: MRI findings and literature review.

Authors:  J Steiner; C Adamsbaum; I Desguerres; G Lalande; F Raynaud; G Ponsot; G Kalifa
Journal:  Pediatr Radiol       Date:  1996-11

7.  Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study.

Authors:  Y-C Zhu; C Dufouil; B Mazoyer; A Soumaré; F Ricolfi; C Tzourio; H Chabriat
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

8.  Characterization of MR Imaging-Visible Perivascular Spaces in the White Matter of Healthy Adolescents at 3T.

Authors:  J Piantino; E L Boespflug; D L Schwartz; M Luther; A M Morales; A Lin; R V Fossen; L Silbert; B J Nagel
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-08       Impact factor: 3.825

Review 9.  [Importance of Virchow-Robin spaces].

Authors:  W Reith; A Haußmann
Journal:  Radiologe       Date:  2018-02       Impact factor: 0.635

10.  MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis.

Authors:  Daniela Prayer; Nicole Grois; Helmut Prosch; Helmut Gadner; Anthony J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.